Ownership history in UBS Group AG · 5 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in XORTX THERAPEUTICS INC (XRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,401 | +1,167 | +498.7% | 0.00% | $787 | $0.56 |
| 2025 Q3 | REDUCED | 234 | -20,556 | -98.9% | 0.00% | $190 | $0.81 |
| 2025 Q2 | ADDED | 20,790 | +3,362 | +19.3% | 0.00% | $19K | $0.90 |
| 2024 Q4 | REDUCED | 17,428 | -1,352 | -7.2% | 0.00% | $20K | $1.13 |
| 2024 Q3 | INITIATED | 18,780 | — | — | 0.00% | $31K | $1.64 |
As of 2025 Q4 — sorted by position size